🔮 Better than the Oracle? Our Fair Value found this +42% bagger 5 months before Buffett bought itRead More

U.S. confirms 9 monkeypox cases in 7 states

Published 05/26/2022, 01:12 PM
Updated 05/26/2022, 07:57 PM
© Reuters. FILE PHOTO: Test tubes labelled "Monkeypox virus positive and negative" are seen in this illustration taken May 23, 2022. REUTERS/Dado Ruvic/Illustration

By Kanishka Singh

WASHINGTON (Reuters) - The United States on Thursday said it had identified nine monkeypox cases in seven states, some in individuals who did not have a recent history of international travel.

As of Wednesday, the nine cases were confirmed in Massachusetts, Florida, Utah, Washington, California, Virginia and New York, the U.S. Centers for Diseases Control and Prevention (CDC) told reporters.

Most of the infections detected globally so far have not been severe. Many, but not all, have been reported in men who have sex with men. Symptoms include fever and a distinctive bumpy rash.

All of the U.S. cases "are within gay, bisexual men and other men who have sex with men," CDC Director Rochelle Walensky said in a news briefing. Walensky urged an approach that is "guided by science, not by stigma."

Over 20 countries where monkeypox is not endemic have reported outbreaks of the viral disease, with about 200 confirmed and more than 100 suspected cases of infections, mostly in Europe. The World Health Organization urged countries to increase surveillance for monkeypox.

The first monkeypox case in the United States was reported in Massachusetts last week.

Some of the nine cases identified as of Wednesday have a recent history of international travel to areas with active monkeypox outbreaks but "others do not", the CDC director said on Thursday.

© Reuters. FILE PHOTO: Test tube labelled

The disease, which mostly occurs in west and central Africa, is a viral infection that was first recorded in the Democratic Republic of Congo in the 1970s.

"We shouldn't be surprised to see more cases reported in the U.S. in the upcoming days," Raj Panjabi, White House senior director for health security and biodefense, said in the press briefing.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.